Premium-Grade Research Peptides You Can Trust!!
The combination of the BPC-157 and TB-500 peptides is often referred to as the “Wolverine” protocol within the industry for it’s powerful healing potential.
BPC-157 and TB-500 provide a wide range of benefits including reduction of inflammation (and inflammation induced pain) and repair of damaged tissue, including both internal injuries and external wounds. Studies have also found that little to no scar tissue is produced during injury and wound repair with this peptide combination.
As a result, users can experience a reduction of pain and inflammation, increased healing times for injuries and wounds, and an increase in athletic performance.
Enhanced purity standards with third-party verification and GMP certification.
Recommended Dose: Inject 5 units (500mcg) daily.
Administration: Subcutaneous injection
Timing: On an empty stomach, at least 1 hour before/after eating..
Cycle: Best results occur when taken consistently for 4-12 weeks.
99% Purity tested via HPLC methods.
Store in a cool and dry place away from children.
6 vials, all supplies included
17 vials, all supplies included
Using our dosage recommendations listed above, 1 vial will provide 40 500mcg (5 unit) doses, lasting 5.71 weeks.Due to the overage of peptide solution in the vial, we provide extra syringes and wipes to ensure the entirety of the vial can be used, if desired. However, only 28 doses are needed for the 4 week protocol.
Using our dosage recommendations listed above, 3 vials will provide 120 500mcg (5 unit) doses, lasting 17.14 weeks.Due to the overage of peptide solution in the vial, we provide extra syringes and wipes to ensure the entirety of the vials can be used, if desired. However, only 84 doses are needed for the 12 week protocol.
This study on rat Achilles tendon fibroblasts demonstrated that BPC-157 (at 0.1–0.5 μg/mL) dose- and time-dependently boosted growth hormone receptor (GHR) expression up to 7-fold, amplifying growth hormone's proliferative effects via the JAK-STAT pathway, with enhanced cell growth and signaling. It suggests BPC-157's promise for accelerating tendon regeneration in injuries.
Read StudyThis review synthesizes preclinical and clinical data showing Thymosin β4 (TB-500) enhances angiogenesis, cell proliferation, and anti-inflammation via pathways like PI3K/Akt and NF-κB, reducing infarct size in heart models, accelerating wound healing in skin and cornea, and alleviating fibrosis in liver/kidney.
Read StudyThis systematic review of 36 studies showed BPC-157 promotes angiogenesis, cell growth, and inflammation reduction (e.g., lowering IL-6 and TNF-α) in models of muscle, tendon, ligament, and bone injuries, improving functional outcomes like Achilles tendon healing in rats and knee pain relief in humans.
Read Study



Based on 0 reviews
You must be logged in to post a review.
There are no reviews yet.
Reviews